Clinical Phenotypes of Parkinson’s Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes
Open Access
- 22 January 2021
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 11 (2), 144
- https://doi.org/10.3390/biom11020144
Abstract
Parkinson’s disease (PD) is a clinically heterogenic disorder characterized by distinct clinical entities. Most studies on motor deficits dichotomize PD into tremor dominant (TD) or non-tremor dominant (non-TD) with akinetic-rigid features (AR). Different pathophysiological mechanisms may affect the onset of motor manifestations. Recent studies have suggested that gut microbes may be involved in PD pathogenesis. The aim of this study was to investigate the gut microbiota and metabolome composition in PD patients in relation to TD and non-TD phenotypes. In order to address this issue, gut microbiota and the metabolome structure of PD patients were determined from faecal samples using 16S next generation sequencing and gas chromatography–mass spectrometry approaches. The results showed a reduction in the relative abundance of Lachnospiraceae, Blautia, Coprococcus, Lachnospira, and an increase in Enterobacteriaceae, Escherichia and Serratia linked to non-TD subtypes. Moreover, the levels of important molecules (i.e., nicotinic acid, cadaverine, glucuronic acid) were altered in relation to the severity of phenotype. We hypothesize that the microbiota/metabolome enterotypes associated to non-TD subtypes may favor the development of gut inflammatory environment and gastrointestinal dysfunctions and therefore a more severe α-synucleinopathy. This study adds important information to PD pathogenesis and emphasizes the potential pathophysiological link between gut microbiota/metabolites and PD motor subtypes.Funding Information
- Fondazione di Sardegna (20612/2018)
This publication has 84 references indexed in Scilit:
- Meta‐analysis of early nonmotor features and risk factors for Parkinson diseaseAnnals of Neurology, 2012
- Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's DiseasePLOS ONE, 2011
- Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s DiseaseEnvironmental Health Perspectives, 2011
- Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with SymptomsPLOS ONE, 2010
- Short-Chain Fatty Acids Regulate the Enteric Neurons and Control Gastrointestinal Motility in RatsGastroenterology, 2010
- Medical records documentation of constipation preceding Parkinson diseaseNeurology, 2009
- Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium‐dependent potassium channel openingJournal of Cellular and Molecular Medicine, 2009
- Endotoxin: is it an environmental factor in the cause of Parkinson's disease?Occupational and Environmental Medicine, 2003
- Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogenJournal of Neural Transmission, 2003
- Single unit analysis of the human ventral thalamic nuclear groupBrain, 1994